arrow
L

Lata Rani

all-india institute of medical sciences
H指数:18
被引数:2,666

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of venetoclax‐based therapies on CLL‐associated autoimmune cytopenias: A retrospective study conducted by ERIC

维奈克拉为基础疗法对CLL相关自身免疫性血细胞减少症的影响:ERIC开展的一项回顾性研究

2026-11-060
OAAI
Application of Targeted RNA-Sequencing in High-Risk B-Cell Acute Lymphoblastic Leukemia (B-ALL): Identifying Fusions, IKZF1 Deletions, and CRLF2 Expression in an Indian Cohort

靶向RNA测序在高风险B细胞急性淋巴细胞白血病(B-ALL)中的应用:识别融合基因、IKZF1缺失以及CRLF2表达在一个印度队列中

2025-09-010
PRE
A prospective cohort study to develop multi-biomarkers panel to define biological ageing in six different cohorts from newborn to oldest adult: a study protocol

一项前瞻性队列研究,旨在开发多生物标志物组合,以定义从新生儿到最年长成年人的六个不同队列中的生物衰老:一项研究方案

2025-01-010
OA
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

CLL历史上的其他恶性肿瘤: ERIC进行的一项国际多中心研究,欧洲CLL研究倡议,和谐

2023-11-016
OAAI
Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India

印度德尔塔和奥密克戎变异株流行期间SARS-CoV-2的系统发育与进化

2023-06-153
PRE
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Dec, 10.1038/s41375-022-01802-y, 2022)
LEUKEMIA
IF13.4
2023-01-121
OAAI
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
LEUKEMIA
IF13.4
2022-12-2429
OAAI